Comment on: Anti-NOR90 antibody associated with paraneoplastic systemic sclerosis

Clin Exp Rheumatol. 2023 Aug;41(8):1720. doi: 10.55563/clinexprheumatol/30kfq2. Epub 2023 Feb 21.

Authors

Cristina Valero¹, Esther F Vicente-Rabaneda¹, Patricia Quiroga-Colina¹, Rosario García-Vicuña¹, Arantzazu Alfranca², Santos Castañeda³

Affiliations

¹ Rheumatology Unit, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
² Immunology Service, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
³ Rheumatology Unit, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, and Cátedra UAM-ROCHE, EPID-Future, Department of Medicine, Universidad Autónoma de Madrid (UAM), Madrid, Spain. scastas@gmail.com, santos.castaneda@salud.madrid.org.

PMID: 36826797
DOI: 10.55563/clinexprheumatol/30kfq2

No abstract available

Publication types

Letter
Comment

MeSH terms

Autoantibodies*
Humans
Scleroderma, Systemic* / complications
Scleroderma, Systemic* / diagnosis

Substances

Autoantibodies